IMPORTANT: PLEASE READ

Similar documents
PART III: CONSUMER INFORMATION

IMPORTANT: PLEASE READ

PATIENT INFORMATION NASONEX [nā-zə-neks] 50 mcg (mometasone furoate monohydrate) Nasal Spray For Intranasal Use Only Read the Patient Information

1 What Flixonase is and what it is used for

Fluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR.

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

PART III: CONSUMER INFORMATION

Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate)

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate

Package leaflet: Information for the user. Nasacort 55 micrograms/dose, nasal spray suspension Triamcinolone acetonide

TAFEN NASAL 50mcg nasal spray, suspension

Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

IMPORTANT: PLEASE READ

PRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard

Package leaflet: Information for the patient. Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

Patient Information ASMANEX HFA (AZ-ma-neks) (mometasone furoate) Inhalation Aerosol What is ASMANEX HFA?

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

ASMANEX Twisthaler Mometasone Furoate Dry Powder Inhaler

OXEZE TURBUHALER formoterol fumarate dihydrate

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

IMPORTANT: PLEASE READ

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

IMPORTANT: PLEASE READ

Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide

ONBREZ BREEZHALER should only be used to treat COPD.

PATIENT INFORMATION LEAFLET

DULERA [dew-lair-ah] 100 mcg/5 mcg DULERA 200 mcg/5 mcg What is DULERA? DULERA is not used to relieve sudden breathing problems Do not use DULERA:

PATIENT INFORMATION BREO ELLIPTA

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

MEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol

The capsule shell contains hypromellose, purified water, carrageenan, potassium chloride and FDC Yellow 6 (110 Sunset Yellow FCF).

FLIXOTIDE CFC-FREE INHALER and JUNIOR CFC-FREE INHALER ['PUFFER'] Fluticasone propionate Consumer Medicine Information

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation

Please read this leaflet carefully before you start using Fluticasone Cipla Inhaler.

PRODUCT MONOGRAPH TARCEVA. erlotinib hydrochloride tablets. erlotinib 25, 100, 150 mg

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation

INFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT

FLIXONASE NASULE DROPS Fluticasone propionate

Package leaflet: Information for the patient. Icsori 250 microgram per actuation pressurised inhalation, suspension. fluticasone propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

BrinzoQuin Eye Drops 1.0%

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

FLIXONASE NASULE DROPS

Flixonase TM Aqueous Nasal Spray

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

your breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems.

IMPORTANT: PLEASE READ

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative

Beclazone CFC-Free Inhaler

Easyhaler Beclometasone 200 micrograms/dose inhalation powder

1 What Flixotide is and what it is used for

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

Package leaflet: Information for the user

PATIENT INFORMATION INCRUSE ELLIPTA

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide

PRODUCT MONOGRAPH. obinutuzumab. 25 mg/ml Concentrate for Solution for Infusion. Professed Standard. Antineoplastic

PATIENT MEDICATION INFORMATION

o change in your mental condition, such as confusion, or decreased awareness or alertness o drowsiness

FLIXOTIDE NEBULES Fluticasone propionate

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

PART III: CONSUMER INFORMATION XOLAIR (omalizumab)

FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation

PRESCRIBING INFORMATION

Package leaflet: Information for the user. Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

Flixotide Accuhaler 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PRODUCT MONOGRAPH. capecitabine. Tablets 150 mg and 500 mg. Manufacturer s Standard. Antineoplastic Agent. Date of Revision: February 10, 2017

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AIM-oh-vig Pr AIMOVIG (erenumab injection)

PATIENT INFORMATION NARCAN (nar kan) (naloxone hydrochloride) Nasal Spray

1 What Flixotide is and what it is used for

MEDICATION GUIDE ANORO ELLIPTA

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. LEMTRADA (alemtuzumab)

Package leaflet: Information for the user. Nasonex 50 micrograms/actuation Nasal Spray, Suspension. Mometasone Furoate

PART III: CONSUMER INFORMATION

Acthar TREATMENT JOURNAL

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

PATIENT INFORMATION LEAFLET

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

CIPROXIN HC Ear Drops

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION SPINRAZA nusinersen injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Palbociclib Capsules

FOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS. Treatment Journal. H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis.

hydrochloride) from the mouthpiece. PART III: CONSUMER INFORMATION

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

NEVANAC TM 0.1% Eye Drops

IMPORTANT: PLEASE READ

VOLTAREN OPHTHA Eye Drops 0.1%

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nasonex 50 micrograms/actuation Nasal Spray, suspension. Mometasone Furoate

Transcription:

PART III: CONSUMER INFORMATION Pr AVAMYS fluticasone furoate nasal spray FOR NASAL USE ONLY This leaflet is part III of a three-part "Product Monograph" published when AVAMYS was approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about AVAMYS. Contact your doctor or pharmacist if you have any questions about the drug. This medicine is for you. Only a doctor can prescribe it to you. Never give it to someone else. It may harm them even if their symptoms are the same as yours. ABOUT THIS MEDICATION What the medication is used for: In adults, adolescents and children 2 years of age and older, AVAMYS is used to treat the symptoms of: Seasonal allergic rhinitis: also called hay fever ; Perennial allergic rhinitis: year round allergies. What it does: When you spray AVAMYS into your nose, it helps reduce the symptoms of seasonal allergies, such as stuffiness, runniness, itching, sneezing, eye redness, itchy eyes, and watery eyes. When it should not be used: Do not use AVAMYS if you are allergic to it or any of its ingredients (see What the medicinal and nonmedicinal ingredients are below). What the medicinal ingredient is: fluticasone furoate What the nonmedicinal ingredients are: 0.015% w/w benzalkonium chloride, dextrose anhydrous, edetate disodium, microcrystalline cellulose and carboxymethylcellulose sodium, polysorbate 80 and purified water. What dosage forms it comes in: nasal spray; 27.5 mcg/metered spray WARNINGS AND PRECAUTIONS This medicine is for use in the nose only. Do not spray it in your eyes or mouth. Before you use AVAMYS talk to your doctor or pharmacist if you: Are pregnant (or planning to become pregnant). Are breastfeeding a baby. Are allergic to AVAMYS or any other corticosteroid. Are suffering from liver disease. Are exposed to chickenpox or measles. Are recovering from recent surgery, trauma or ulcers to your nose. Have tuberculosis or any untreated fungal, bacterial, or viral infections. Have untreated eye infections caused by herpes Drugs like AVAMYS can cause eye disorders: Cataracts: Clouding of the lens in the eye, blurry vision, eye pain; Glaucoma: An increased pressure in your eyes, eye pain. Untreated, it may lead to permanent vision loss. You should therefore have regular eye exams. This medicine has been prescribed for you by your doctor. Do not give this medicine to anyone else. INTERACTIONS WITH THIS MEDICATION Make sure that your doctor knows what other medicines you are taking (such as those for allergies, nervousness, depression, migraine, etc.), including those you can buy without a prescription as well as herbal and alternative medicines. It is especially important to tell your doctor if you are taking, or have recently taken any of the following medicines: steroid tablets or injected steroids steroid creams medicines for asthma ritonavir, used to treat HIV ketoconazole, used to treat fungal infections AVAMYS will deliver either 30 or 120 sprays. Page 43 of 47

PROPER USE OF THIS MEDICATION Shake well before use. Usual dose: For patients 12 years and older, the usual dosage is 2 sprays in each nostril once a day. It doesn t matter when you take your dose but take it at the same time every day. For children aged 2 to less than 12 years, the usual starting dosage is 1 spray in each nostril, once a day. Some people may need two sprays in each nostril once a day until their symptoms are properly controlled and then their doctor may reduce their dose. Always follow your doctor s recommendations. It is important that you use AVAMYS as your doctor has told you. Do not take more of your medicine or take it more often than your doctor tells you. The prescription label will usually tell you how many sprays to take and how often. If it does not or if you are not sure, ask your doctor or pharmacist. Do not use AVAMYS for more than the number of sprays printed on the label even though the bottle is not completely empty. After the labelled number of sprays, the amount of drug delivered per spray may not be consistent. Do not take extra doses of AVAMYS without telling your doctor. If your condition worsens after 24 hours of use, contact your doctor. AVAMYS may begin to work within 8 to 24 hours after you take your first dose. However, it may take several days of treatment to achieve its greatest effect. You will get the best results if you keep using AVAMYS regularly each day without missing a dose. If your symptoms do not improve, contact your doctor. Overdose: If you think you have taken too much AVAMYS contact your doctor, pharmacist, hospital emergency department or regional Poison control Centre immediately, even if there are no symptoms. The Cap keeps the Mist-Release Button from being pressed by mistake. It also helps keep the nozzle clean. Do not throw the cap away. Always keep the cap on when you are not using it. The Nozzle is small and short, so it will fit comfortably inside your nose. The medicine comes out from the nozzle. Pressing the Mist-Release Button sprays a measured amount of medicine from the nozzle as a gentle, fine mist. Because the button is on the side of the device, it is easy for you to keep the nozzle in the right place in your nose while you press the button. AVAMYS comes in a brown glass bottle inside a plastic casing. The Window in the plastic casing lets you see how much medicine is left in the bottle. To check how much is left hold the nasal spray upright against a bright light; you will be able to see the liquid level if it is low. Bottles containing 30 sprays will not appear full when you first receive them. Missed Dose: If you miss a dose by several hours, just take your next dose at the usual time. Do not take an extra dose. The parts of AVAMYS : AVAMYS comes in an easy-to-use nasal spray device which contains a glass bottle. Page 44 of 47

How to prime AVAMYS (i.e. How to make AVAMYS ready to use): Prime AVAMYS before using it for the first time. This helps to make sure you always get the same full dose of medicine: 1. With the cap on, shake AVAMYS well. 2. Take the cap off by squeezing the finger grips and pulling it straight off. Do not press the button while you take off the cap. 3. Hold the device with the nozzle pointing up and away from you. Firmly press the button on the side all the way in to release a spray through the nozzle. If you have difficulty pressing the button with your thumb, you can use both hands. Press and release the button 6 times or until a fine mist is sprayed from the nozzle. AVAMYS is now ready to use. Shake well before each use. AVAMYS is provided in an easy-to-use device. Before taking a dose of AVAMYS, gently blow your nose to clear your nostrils. Then do these 3 simple steps: Place, Press, Repeat. 1. Place Tilt your head forward a little bit. Hold AVAMYS upright. Place the nozzle in one of your nostrils. Point the end of the nozzle toward the side of your nose, away from the center of your nose. This helps get the medicine to the right part of your nose. 2. Press Firmly Press the button 1 time to spray the medicine in your nose while you are breathing in through your nose. Do not get any spray in your eyes. If you do, rinse your eyes well with water. Take the nozzle out of your nose. Breathe out through your mouth. 4. Remember to prime AVAMYS whenever: You use a new bottle for the first time. You have not used AVAMYS for 30 days or longer. The cap has been left off the bottle for 5 days or longer. 5. If you accidentally drop AVAMYS check it for damage and prime it again. If the device is damaged, or if it produces anything other than a fine mist (such as a jet of liquid) or if you feel any discomfort while using the spray, do not use it. Consult with your pharmacist. How to use AVAMYS : Follow the instructions below. If you have any questions, ask your doctor or pharmacist. Page 45 of 47

3. Repeat Steps 1 and 2 in the other nostril. Take number of sprays in each nostril as directed by your physician. Put the cap back on the device after you have finished taking your dose. How to clean AVAMYS : 1. After each use, wipe the nozzle with a clean, dry tissue. If the spray becomes blocked, never try to clean the nozzle with a pin or anything sharp because this may damage the spray mechanism. If it does not work, consult with your pharmacist. 2. Once a week, clean the inside of the cap with a clean, dry tissue. This will help keep the nozzle from getting blocked. Side effects that may occur with the use of corticosteroid nasal sprays are: Slower healing of wounds. Do not use AVAMYS until your nose has healed if you have a sore in your nose, if you have surgery on your nose, or if your nose has been injured. Worsening of the symptoms of infections such as existing tuberculosis, fungal, bacterial or parasitic infections or herpes of the eye. Slower growth in children (5-9 years of age) has occurred with use of AVAMYS. Slower growth in adolescents (12-17 years of age) may occur with use of corticosteroid nasal sprays. Your physician should monitor your growth regularly if you are in these age groups. If any of these affects you severely, tell your doctor, nurse or pharmacist. SERIOUS SIDE EFFECTS SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM Symptom / effect Rare Allergic Reactions: Rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing. Talk with your doctor or pharmacist Only if severe In all cases Stop taking drug and seek emergency medical assistance Fungal infection in the nose. Decreased Adrenal Function: tiredness, weakness, nausea and vomiting, low blood pressure. Slowed growth in children and adolescents. Hyperglycemia (Increased amount of sugar in blood): Excessive thirst, frequent urination, dry skin, blurred vision and fatigue. High Blood Pressure: headaches, vision disorders, nausea and vomiting. Nasal septum perforation: small holes in the wall between the 2 nostrils SIDE EFFECTS AND WHAT TO DO ABOUT THEM Side effects may include: nose bleeds; nasal ulcers; pain, burning, irritation, soreness or dryness in the inside of the nose sore throat, upper respiratory tract infection, fever, bronchitis, cough, stuffy nose headache nausea back pain dizziness shortness of breath a feeling that your heart is racing Very Rare Page 46 of 47

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM Symptom / effect Unknown Cushing s Syndrome: Rapid weight gain especially around the body and face. Round "moon face", excess sweating, and thinning of the skin with easy bruising and dryness, muscle and bone weakness. Glaucoma: increased pressure in your eyes, eye pain. Cataract: Clouding of the lens in the eye, blurry vision, and/or eye pain. Talk with your doctor or pharmacist Only if severe In all cases Stop taking drug and seek emergency medical assistance This is not a complete list of side effects. For any unexpected effects while taking AVAMYS, contact your doctor or pharmacist. HOW TO STORE IT Keep AVAMYS in a safe place where children cannot reach it. Your medicine may harm them. Store the device between 4 C and 30 C, in the upright position with the cap in place. Do not refrigerate or freeze. REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: Report online at www.healthcanada.gc.ca/medeffect Call toll-free at 1-866-234-2345 Complete a Canada Vigilance Reporting Form and: - Fax toll-free to 1-866-678-6789, or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701E Ottawa, ON K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect. NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the full product monograph, prepared for health professionals can be found at: http://www.gsk.ca or by contacting the sponsor, GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4 1-800-387-7374 This leaflet was prepared by GlaxoSmithKline Inc. Last revised: August 31, 2015 2015 GlaxoSmithKline Inc. All Rights Reserved. AVAMYS is a registered trademark of Glaxo Group Limited, used under license by GlaxoSmithKline Inc. Page 47 of 47